Laurus Labs Limited
LAURUSLABSDrug Manufacturers - Specialty & Generic
₹2,405.50+7.20%As of Oct 30vs prior close
- Market cap
- $13.7B
- P/E (TTM)
- 97.1×
- P/E (FY1)
- 94.7×
- From 52W high
- 0.00%
- EPS (LTM)
- ₹20.23
- Revenue (LTM)
- ₹72.7B
- Net margin
- 17.13%
- Dividend yield
- 0.08%
Nomior Score
65
Ascendant MoverTop 16% of the scored universe
Growth68
Quality56
Value24
Momentum98
Resilience53
Growth
+3.77%revenue a year over 3 fiscal years
YE23 ₹60.1BLTM ₹72.7B
Connections
Revenue to profitYE26
13% of revenue became net profit, up 7 pts on a year.